X

Biotechnology

Avalo Therapeutics CEO Mike Cola on product pipeline and market potential

Credit:DavidBGray on iStock What’s the significance of the name change and why now? Mike: The why now is because we…

Avid Bioservices Inc (CDMO) Q1 2021 Earnings Call Transcript

Avid Bioservices Inc (NASDAQ: CDMO) Q1 2021 earnings call dated Sep. 08, 2021. Corporate Participants: Tim Brons -- Avid's Investor Relations…

IPO Alert: COVID-19 test maker Cue Health is all set to go public

Just eight months into the year, IPO activity has already reached all-time highs, with tech firms and biotechnology startups leading…

Moderna (MRNA): Here are a few points to note while considering this stock

Shares of Moderna Inc. (NASDAQ: MRNA) were up 6% on Monday. The stock has gained 291% since the beginning of…

IPO Alert: What investors need to know about Procept BioRobotics’ upcoming market debut

The medical device market has been in the spotlight ever since coronavirus tightened its grip across the world last year…

IPO News: Should you invest in RenovoRx’s upcoming IPO?

As healthcare startups continue to flock to the stock market, extending the hectic activity seen in the first half, the…

Cara Therapeutics, Inc. CARA) Q2 2021 Earnings Call Transcript

Cara Therapeutics, Inc. (NASDAQ: CARA) Q2 2021 earnings call dated Aug. 09, 2021 Corporate Participants: Cole Herlitz-Ferguson -- Investor Relations Derek Chalmers -- Chief…

IPO News: What to look for when Eliem Therapeutics goes public?

Extending the IPO frenzy that sweeped the market in the early part of the year, emerging biotechnology companies continue to…

Moderna, Inc. (MRNA) Q2 2021 Earnings Call Transcript

Moderna, Inc. (NASDAQ: MRNA) Q2 2021 earnings call dated Aug. 05, 2021 Corporate Participants: Lavina Talukdar -- Senior Vice President & Head…

Jazz Pharmaceuticals PLC (JAZZ) Q2 2021 Earnings Call Transcript

Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q2 2021 earnings call dated Aug. 03, 2021 Corporate Participants: Andrea N. Flynn -- Vice President and…

IPO News: What awaits Adagio Therapeutics after stock market debut?

The favorable regulatory environment and convenient options like direct listing continue to lure emerging businesses to the stock market. The…

IPO News: Here’s everything you need to know about Healthcare Royalty’s upcoming IPO

In the first half of 2021, a record number of private companies entered stock markets in the US, marking a…

ImmunoGen Inc. (IMGN) Q2 2021 Earnings Call Transcript

ImmunoGen Inc. (NASDAQ: IMGN) Q2 2021 earnings call dated Jul. 30, 2021 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications…

Gilead Sciences Inc (GILD) Q2 2021 Earnings Call Transcript

Gilead Sciences Inc (NASDAQ: GILD) Q2 2021 earnings call dated Jul. 29, 2021. Corporate Participants: Jacquie Ross -- Investor Relations Daniel…

WCG Clinical IPO: Here’s what you should know before investing in the stock

Of late healthcare firms have been flocking to Wall Street, betting on the booming stock market to take their business…

Biogen (BIIB) Earnings Infographic: Q2 profit, revenue drop but top estimates

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Thursday said its second-quarter earnings and revenues decreased from last year. The results, however,…

Absci IPO: Here’s all you need to know about bioengineering firm’s Nasdaq listing

Wall Street is probably going through the busiest phase since the recession, in terms of the number of businesses seeking…

IPO News: Here’s what to know when Sera Prognostics goes public this week

The healthcare industry continues to grow at a rapid pace with diagnostic services playing an important role in this space.…

Avid Bioservices, Inc. (CDMO) Q4 2021 Earnings Call Transcript

Avid Bioservices, Inc. (NASDAQ: CDMO) Q4 2021 earnings call dated Jun. 29, 2021 Corporate Participants: Tim Brons -- Executive Vice President, Vida…

Thermo Fisher (TMO) stock can add value to your portfolio. Here’s why

For Thermo Fisher Scientific Inc. (NYSE: TMO), a leading player in the medical diagnostics and life sciences market, 2020 was…

Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?

The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for…